Gainers
- Monogram Orthopaedics MGRM stock increased by 19.1% to $2.31 during Monday's pre-market session. The company's market cap stands at $73.1 million.
- Allarity Therapeutics ALLR shares moved upwards by 13.99% to $1.14. The market value of their outstanding shares is at $2.2 million.
- VYNE Therapeutics VYNE shares increased by 13.74% to $2.98. The company's market cap stands at $42.0 million.
- Allogene Therapeutics ALLO stock increased by 13.02% to $3.47. The market value of their outstanding shares is at $592.4 million.
- Sunshine Biopharma SBFM stock rose 12.55% to $0.95.
- Addex Therapeutics ADXN shares increased by 12.4% to $10.06. The company's market cap stands at $10.7 million.
Losers
- GlycoMimetics GLYC shares decreased by 78.7% to $0.39 during Monday's pre-market session. The market value of their outstanding shares is at $25.0 million.
- Acutus Medical AFIB shares fell 38.57% to $0.09. The market value of their outstanding shares is at $2.6 million.
- EyePoint Pharmaceuticals EYPT shares declined by 33.29% to $13.17. The market value of their outstanding shares is at $685.9 million.
- NeuBase Therapeutics NBSE shares fell 16.47% to $0.34. The company's market cap stands at $1.2 million.
- Ocular Therapeutix OCUL shares declined by 15.08% to $5.24. The market value of their outstanding shares is at $810.7 million.
- Predictive Oncology POAI stock fell 13.82% to $1.56. The company's market cap stands at $6.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AFIBAcutus Medical Inc
$0.0510-%
ALLOAllogene Therapeutics Inc
$1.95-%
ALLRAllarity Therapeutics Inc
$1.04-%
EYPTEyePoint Pharmaceuticals Inc
$7.25-%
GLYCGlycoMimetics Inc
$0.2150-0.69%
MGRMMonogram Technologies Inc
$2.552.00%
OCULOcular Therapeutix Inc
$8.56-%
POAIPredictive Oncology Inc
$0.6500-5.25%
SBFMSunshine Biopharma Inc
$2.84-5.33%
VYNEVYNE Therapeutics Inc
$2.49-3.11%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in